Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q484
SBA

SBA — Single Best Answer · Review

Question 484

Pharmacology → General

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID c85cf102-4070-4268-ba42-690bda94f992

Classification

Speciality
Obstetrics and Gynaecology
Group
Basic
Title
Pharmacology
Topic
General
Subtopic 1
Drugs Interfering with Glucose Metabolism
Subtopic 2
Sulphonylureas
Subtopic 3
Placental and hypoglycaemic effects
Question Type
SBA

Question

SSBA
Question Header
A sulphonylurea is being considered in a woman who may become pregnant. Which combination of properties is most characteristic of this drug class?
Question Stem
Select the single best answer.

Options

A They do not cross the placenta and hyperglycaemia is their most common adverse effect
B They cross the placenta and may stimulate fetal beta cells; hypoglycaemia is their most common adverse effect
C They require complete absence of endogenous insulin and commonly cause hyperuricaemia
D They improve insulin sensitivity without placental transfer and do not cause hypoglycaemia
E They inhibit renal prostaglandin synthesis and may prematurely close the ductus arteriosus

Explanation

Sulphonylureas cross the placenta and may cause fetal beta-cell stimulation. Hypoglycaemia is their most common adverse effect and can occasionally be severe. Tolbutamide has the lowest risk because of its low potency and short duration of action.

Option Validity

A) Sulphonylureas cross the placenta, and hypoglycaemia rather than hyperglycaemia is their most common adverse effect.

C) Requirement for residual endogenous insulin is a property described for biguanide action; hyperuricaemia is associated with diuretic therapy.

D) Improvement of insulin sensitivity without causing hypoglycaemia characterises metformin rather than sulphonylureas.

E) Inhibition of renal prostaglandin synthesis and the risk of premature ductal closure are associated with NSAIDs.

Further Reading

Saxena R. Textbook for MRCOG-1. Chapter 12: Pharmacology. Drugs Interfering with Glucose Metabolism, p.347.

Source & metrics

Authored Difficulty
6.00
Evaluation Score
—
Destination
Site
Source
Saxena - MRCOG-1 Basic Sciences - Pharmacology - General
Source Section
Drugs Interfering with Glucose Metabolism
Source Locator
Chapter 12, p.347
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question